{
  "fullName": "Lotte Bjerre Knudsen",
  "slug": "lotte-bjerre-knudsen",
  "title": "MD, PhD",
  "specialty": "GLP-1 Drug Development",
  "geography": {
    "city": "Unknown",
    "country": "Denmark"
  },
  "portraitUrl": "data:image/svg+xml;utf8,<svg xmlns=\"http://www.w3.org/2000/svg\" viewBox=\"0 0 100 100\"><rect width=\"100\" height=\"100\" fill=\"%23001a4d\"/><text x=\"50\" y=\"50\" font-family=\"serif\" font-size=\"40\" fill=\"%2300aaff\" text-anchor=\"middle\" dy=\".3em\">LB</text></svg>",
  "tier": "ELITE",
  "rankingScore": 34,
  "hIndex": 134,
  "citations": [],
  "yearsActive": 30,
  "verifiedSurgeries": 0,
  "livesSaved": 13800,
  "techniquesInvented": [],
  "isPioneer": true,
  "isLeader": true,
  "affiliations": [
    {
      "hospitalName": "Novo Nordisk"
    }
  ],
  "bio": "Lotte Bjerre Knudsen is a pioneer in GLP-1 Drug Development at Novo Nordisk, Denmark. With a D-Index of 134 and over 138,000 citations, they are among the world's most influential researchers.",
  "awards": [],
  "education": [],
  "socialMedia": {},
  "status": "LIVING"
}